Genappe Pharma Invest SRL
Genappe Pharma Invest reported total assets of €1.21m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
By total assets for 2025, Genappe Pharma Invest ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Genappe Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +49 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Genappe Pharma Invest's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
Genappe Pharma Invest's financial analysis
- Solvency6.5%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Genappe Pharma Invest
Genappe Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0801.925.031
- VAT number
- BE0801925031
- Peppol
- Registered · 0208:0801925031 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 May 2023
- Registered office
- 1470 Genappe
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Genappe Pharma Invest (SRL) has been based in Genappe since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 18,412 € and equity of 78,918 €; its revenue is not published. Its solvency stands at 6.5%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Genappe Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Delvaux Holding Business and other management consultancy activities Herstal · balance sheet €1.10m
- TM Pharma Business and other management consultancy activities Edegem · balance sheet €1.68m
- Mathis Pharma Business and other management consultancy activities Bruges · balance sheet €1.06m
- T-Oline Business and other management consultancy activities Ferrières · balance sheet 987,312 €
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- GOME Retail sale of pharmaceutical products Beerse · balance sheet €1.28m
- V-cares Retail sale of pharmaceutical products Zonhoven · balance sheet €1.07m
- Pharmacie Overlo Retail sale of pharmaceutical products Silly · balance sheet 754,243 €
Frequently asked questions about Genappe Pharma Invest
What is the revenue of Genappe Pharma Invest?
Genappe Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Genappe Pharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0801925031 for Genappe Pharma Invest, if the company is VAT-registered. Its company number (CBE) is 0801.925.031.
Where is the registered office of Genappe Pharma Invest?
According to the CBE register, the registered office of Genappe Pharma Invest is in 1470 Genappe.
What is the equity of Genappe Pharma Invest?
At the close of the 2025 financial year, the equity of Genappe Pharma Invest amounts to 78,918 €, a solvency of 6.5% of total assets.
Who manages Genappe Pharma Invest?
The register lists 5 active mandates at Genappe Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Genappe Pharma Invest within its sector?
By total assets for 2025, Genappe Pharma Invest ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Genappe Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →